Rules and Regulations. Final rule; correction
/register/2014/09/08/2014-21266·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Agency: Food and Drug Administration, HHS
Action: Final rule; correction
Citation: FR Doc. 2014-21266 · RIN 0910-AF96 · Docket No. FDA-2008-N-0334 · 21 CFR 310, 314, 329, 600
Summary
The Food and Drug Administration (FDA) is correcting a final rule entitled “Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements” that appeared in the Federal Register of June 10, 2014 (79 FR 33072). The document amended FDA's postmarketing safety reporting regulations for human drug and biological products to require that persons subject to mandatory reporting requirements submit safety reports in an electronic format that FDA can process, review, and archive. The document was published with an incorrect RIN number. This document corrects the error.
Dates
Effective date: September 8, 2014.
Supplementary Information
In the Federal Register of June 10, 2014, in FR Doc. 2014-13480, the following correction is made: 1. On page 33073, in the third column, the RIN number heading is corrected to read “RIN 0910-AF96”. Dated: September 2, 2014. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014-21266 Filed 9-5-14; 8:45 am]